ACM
BDSX icon

Asymmetry Capital Management’s Biodesix BDSX Stock Holding History

Asymmetry Capital Management’s Portfolio BDSX Stock Details BDSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-19,069
Closed -$5.04M – 32
2021
Q2 		$5.04M Sell
19,069
-3,134
-14% -$985K 3.46% 14
2021
Q1 		$9.02M Sell
22,203
-1,746
-7% -$780K 4.67% 11
2020
Q4 		$9.66M Buy
+23,949
New +$7.46M 4.4% 8

Other funds holding BDSX

BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PGM
Parian Global Management Pound Ridge, New York $30.8M AUM 51.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Asymmetry Capital Management's BDSX Position: Q3 2021 in Review

Asymmetry Capital Management sold out of Biodesix (BDSX) in Q3 2021, closing a stake of 19,069 shares — an estimated $5.04M sold.

Asymmetry Capital Management first reported a position in BDSX in Q4 2020 and held it in 3 quarters. The position peaked at $9.66M in Q4 2020. 42 funds tracked by Wall St. Rank hold BDSX as of Q3 2021.

  • Asymmetry Capital Management reported no remaining Biodesix position as of Q3 2021 after selling out during the quarter.
  • Asymmetry Capital Management sold 19,069 Biodesix shares in Q3 2021, an estimated $5.04M.
  • Asymmetry Capital Management first reported a position in Biodesix in Q4 2020 and held it in 3 quarters.
  • Asymmetry Capital Management's Biodesix position peaked at $9.66M in Q4 2020.
  • 42 funds tracked by Wall St. Rank held Biodesix as of Q3 2021.

Based on Asymmetry Capital Management's 13F filing for Q3 2021, filed 4 Nov 2021.